SynthesisFrontiers in public health2026
Prevalence and influencing factors of oral frailty in cancer patients: a systematic review and meta-analysis.
Synthesis in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study systematically evaluated the prevalence of oral frailty and its associated influencing factors among patients with cancer through a comprehensive systematic review and meta-analysis. Methods: A systematic search was conducted across nine electronic databases up to January 13, 2026, and 13 studies involving 3,524 participants were ultimately included. Results: The pooled analysis demonstrated that the prevalence of oral frailty in patients with cancer was 52% (95% CI: 46%-59%), indicating a substantial disease burden in this population. Several factors were identified as associated with oral frailty, including denture use (OR = 15.09, 95% CI: 6.78-33.58), poor oral health (OR = 4.70, 95% CI: 2.13-10.39), physical frailty (OR = 3.63, 95% CI: 2.40-5.50), smoking (OR = 3.53, 95% CI: 2.34-5.31), malnutrition (OR = 3.40, 95% CI: 2.01-5.75), xerostomia (OR = 3.46, 95% CI: 2.11-5.68), and radiotherapy (OR = 2.62, 95% CI: 1.67-4.11). Sensitivity analysis confirmed the robustness of the results, and Egger's test indicated no significant publication bias ( Discussion: These findings suggest that oral frailty is relatively common among patients with cancer and is associated with several identifiable factors. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, identifier: CRD420261281120.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.